Misoprostol NDC 68071-4843

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-4843Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-4843Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-4843-3	68071484303	3 TABLET in 1 BOTTLE (68071-4843-3)Marketed from Apr 11, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Misoprostol
Generic name (nonproprietary): misoprostol
Active ingredients: Misoprostol — 200 ug/1
Dosage form: Tablet
Route: Oral
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091667
Marketing start: Jul 25, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Synthetic (Chemical structure)
Identifiers: Product ID 68071-4843_1ae170f1-2117-c3ed-e063-6294a90a6536SPL ID 1ae170f1-2117-c3ed-e063-6294a90a6536SPL set ID 8642b8e4-d1bb-f12a-e053-2a91aa0a14bfRxCUI 317128UNII 0E43V0BB57UPC 0368071484335
Pharmacologic class: Prostaglandin E1 Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071484303 followed by a unit qualifier and the quantity

Package 68071-4843-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 14, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Misoprostol is indicated for reducing the risk of NSAID (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. Misoprostol Tablet has not been shown to reduce the risk of duodenal ulcers in patients taking NSAIDs. Misoprostol Tablets should be taken for the duration of NSAID therapy. Misoprostol Tablets has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months' duration. It had no…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091667

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091667
Product	Strength	Form · route	Labeler	Product NDC
Misoprostol	Misoprostol 200 ug/1	TabletOral	Novel Laboratories, Inc.	40032-161
Misoprostol	Misoprostol 100 ug/1	TabletOral	Novel Laboratories, Inc.	40032-160
Misoprostol	Misoprostol 200 ug/1	TabletOral	PharmPak, Inc.	54348-148
Misoprostol	Misoprostol 200 ug/1	TabletOral	Lupin Pharmaceuticals,Inc.	43386-161
Misoprostol	Misoprostol 100 ug/1	TabletOral	Lupin Pharmaceuticals,Inc.	43386-160